These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17428852)

  • 1. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.
    McCoy K; Tatsis N; Korioth-Schmitz B; Lasaro MO; Hensley SE; Lin SW; Li Y; Giles-Davis W; Cun A; Zhou D; Xiang Z; Letvin NL; Ertl HC
    J Virol; 2007 Jun; 81(12):6594-604. PubMed ID: 17428852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens.
    Tatsis N; Lasaro MO; Lin SW; Haut LH; Xiang ZQ; Zhou D; Dimenna L; Li H; Bian A; Abdulla S; Li Y; Giles-Davis W; Engram J; Ratcliffe SJ; Silvestri G; Ertl HC; Betts MR
    J Immunol; 2009 May; 182(10):6587-99. PubMed ID: 19414814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.
    Tatsis N; Blejer A; Lasaro MO; Hensley SE; Cun A; Tesema L; Li Y; Gao GP; Xiang ZQ; Zhou D; Wilson JM; Ertl HC
    Mol Ther; 2007 Mar; 15(3):608-17. PubMed ID: 17228314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.
    Lorin C; Vanloubbeeck Y; Baudart S; Ska M; Bayat B; Brauers G; Clarinval G; Donner MN; Marchand M; Koutsoukos M; Mettens P; Cohen J; Voss G
    PLoS One; 2015; 10(4):e0122835. PubMed ID: 25856308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimpanzee-origin adenovirus vectors as vaccine carriers.
    Tatsis N; Tesema L; Robinson ER; Giles-Davis W; McCoy K; Gao GP; Wilson JM; Ertl HC
    Gene Ther; 2006 Mar; 13(5):421-9. PubMed ID: 16319951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
    Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
    J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
    Crosby CM; Nehete P; Sastry KJ; Barry MA
    J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.
    Xiang ZQ; Gao GP; Reyes-Sandoval A; Li Y; Wilson JM; Ertl HC
    J Virol; 2003 Oct; 77(20):10780-9. PubMed ID: 14512528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.
    Hensley SE; Giles-Davis W; McCoy KC; Weninger W; Ertl HC
    J Immunol; 2005 Nov; 175(9):6032-41. PubMed ID: 16237098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights on adenovirus as vaccine vectors.
    Lasaro MO; Ertl HC
    Mol Ther; 2009 Aug; 17(8):1333-9. PubMed ID: 19513019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an adenoviral vaccine vector based on simian adenovirus 21.
    Roy S; Zhi Y; Kobinger GP; Figueredo J; Calcedo R; Miller JR; Feldmann H; Wilson JM
    J Gen Virol; 2006 Sep; 87(Pt 9):2477-2485. PubMed ID: 16894185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.
    Hensley SE; Cun AS; Giles-Davis W; Li Y; Xiang Z; Lasaro MO; Williams BR; Silverman RH; Ertl HC
    Mol Ther; 2007 Feb; 15(2):393-403. PubMed ID: 17235319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodominance of Adenovirus-Derived CD8
    Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses.
    Small JC; Haut LH; Bian A; Ertl HC
    J Leukoc Biol; 2014 Nov; 96(5):821-31. PubMed ID: 25082150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
    Fitzgerald JC; Gao GP; Reyes-Sandoval A; Pavlakis GN; Xiang ZQ; Wlazlo AP; Giles-Davis W; Wilson JM; Ertl HC
    J Immunol; 2003 Feb; 170(3):1416-22. PubMed ID: 12538702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
    Xiang Z; Gao G; Reyes-Sandoval A; Cohen CJ; Li Y; Bergelson JM; Wilson JM; Ertl HC
    J Virol; 2002 Mar; 76(6):2667-75. PubMed ID: 11861833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.
    Jeyanathan M; Thanthrige-Don N; Afkhami S; Lai R; Damjanovic D; Zganiacz A; Feng X; Yao XD; Rosenthal KL; Medina MF; Gauldie J; Ertl HC; Xing Z
    Mucosal Immunol; 2015 Nov; 8(6):1373-87. PubMed ID: 25872483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.